Skip to main content
OpenTrials

Clinical trial condition

Paraneoplastic Syndromes, Nervous System

Explore clinical trials studying Paraneoplastic Syndromes, Nervous System. Study availability and eligibility vary by location and protocol.

307 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Paraneoplastic Syndromes, Nervous System trial results

Recruiting

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

NCT06456580

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • HonorHealth Neurology - Bob Bové Neuroscience Institute Scottsdale, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • University of California Irvine Orange, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
View all 111 locations
View Trial Details
Recruiting

Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC

NCT05491525

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +30 more
Locations
  • Arkansas Childrens Hospital Little Rock, Arkansas, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Nemours Childrens Health, Jacksonville Jacksonville, Florida, United States
View all 38 locations
View Trial Details
Recruiting

A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

NCT06744920

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Neuromuscular Research Center Phoenix, Arizona, United States
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Fullerton Neuro and Headache Ctr Fullerton, California, United States
  • University Of Southern California Los Angeles, California, United States
View all 129 locations
View Trial Details
Recruiting

A Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy

NCT07595653

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis (gMG), +12 more
Locations
  • Ospedale Generale Regionale F. Miulli Acquaviva delle Fonti, Italy
  • Azienda Ospedaliero Universitaria delle Marche Ancona, Italy
  • A.O.U. Consorziale Policlinico Bari, Italy
  • ASST Papa Giovanni XXIII Bergamo, Italy
View all 30 locations
View Trial Details
Recruiting

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

NCT07526493

Conditions
Anti-Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disease (MOGAD), Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +37 more
Locations
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details

Related conditions